Drug Profile
Levamlodipine/valsartan - Ahn-Gook Pharmaceuticals
Alternative Names: AGSAV-301; S-amlodipine/valsartan; Valsartan/levamlodipine - Ahn-Gook Pharmaceuticals; Valsartan/S-amlodipineLatest Information Update: 03 Mar 2016
Price :
$50
*
At a glance
- Originator Ahn-Gook Pharmaceutical
- Class Antihypertensives; Branched-chain amino acids; Dihydropyridines; Nicotinic acids; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 03 Mar 2016 No development reported - Phase-I for Hypertension (In volunteers) in South Korea (PO)
- 31 Oct 2013 Pharmacokinetics and adverse event data from a phase I trial in Healthy volunteers released by Ahn-Gook Pharmaceutical
- 21 Feb 2012 Phase-I clinical trials in Hypertension (in volunteers) in South Korea (PO)